HOME Top Market Reports Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: December 2016
Report Code: BT 2680

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The oligonucleotide synthesis market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016. Major factors driving the growth of this market include increasing R&D expenses in the pharmaceutical and biotechnology companies, the rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes.  The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, and genetic engineering and synthetic biology also play a vital role in the development of this market. In addition, emerging Asian markets and the growing field of NGS have opened an array of opportunities for players in the oligonucleotide synthesis market. However, price erosion and a lack of regulations for therapeutic oligonucleotides may hinder the growth of this market.

North America is expected to dominate the global market in 2016, with the U.S. accounting for a major share of this regional market. Falling market prices and increasing awareness about the applications of synthetic genes have also exponentially increased their market demand. In addition, the availability of funds for research from various public and private sector organizations is likely to drive the growth of the North American oligonucleotide synthesis market.

Asia-Pacific oligonucleotide synthesis market is slated to grow at a highest CAGR owing to the growing availability of synthesized oligos. The high growth in this market is attributed to growing R&D funding, rising product availability, low outsourcing costs, and increasing research activities in the region. Furthermore, factors such as the increasing applications of oligonucleotides in molecular diagnostics and therapeutics and increase in the number of oligonucleotide-related conferences in the Asia-Pacific region are further expected to drive market growth. Some prominent markets in APAC include China, India, and Japan.

The oligonucleotide synthesis market is fragmented with several global as well as local players. Players offer several products across different sub-segments of this market. Key players in this market include Agilent Technologies Inc. (U.S.), Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), and Sigma-Aldrich Corporation (U.S.) (part of Merck KGaA).

Target Audience:

  • Pharmaceutical and biotechnology companies
  • Academic researchers/government research organizations
  • Contract manufacturing organizations (CMOS)
  • Custom oligonucleotide service providers
  • Venture capitalists
  • Research and consulting firms
  • Oligonucleotide equipment manufacturers

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the healthcare analytics market into the following segments and sub-segments.

Oligonucleotide Synthesis Market, by Products and Services

  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Intermediate-scale synthesis Oligos
      • Large-scale synthesis Oligos
      • Linkers and Adaptors
    • By Services
      • Custom Oligos
      • Pre-designed Oligos
  • Reagents
  • Equipment

Oligonucleotide Synthesis Market, by Application

  • Research
    • PCR
    • qPCR
    • DNA Sequencing
    • Gene Synthesis
    • Other research applications
  • Diagnostic
  • Therapeutics
    • DNA/Antisense oligos
    • RNA
    • Nucleic acid aptamers
    • Immunotherapy Applications

Oligonucleotide Synthesis Market, by End User

  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Oligonucleotide Synthesis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE (Rest of Europe)
  • Asia-Pacific
    • China
    • India
    • Japan
    • RoA (Rest of Asia)
  • Latin America
  • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 21)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Industry Insights
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 33)

4 Premium Insights (Page No. - 38)
    4.1 Oligonucleotide Synthesis Market Overview
    4.2 Synthesized Oligonucleotides Market, By Product
    4.3 Oligonucleotide Synthesis Market, By Service
    4.4 Oligonucleotide Synthesis Market, By Research Application
    4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
    4.6 Oligonucleotide Synthesis Market, By End User
    4.7 Geographic Snapshot: Oligonucleotide Synthesis Market

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Technological Advancements and R&D Investments in Synthetic Biology
                    5.2.1.2 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
                    5.2.1.3 Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
                    5.2.1.4 Rise in Venture Capital Investments
                    5.2.1.5 Growing Focus on Conferences to Increase Awareness Among Researchers
           5.2.2 Market Restraints
                    5.2.2.1 Price Erosion of Synthesized Oligos
                    5.2.2.2 Lack of Regulations for Therapeutic Oligos
           5.2.3 Market Opportunities
                    5.2.3.1 Emerging Asian Markets
                    5.2.3.2 Developing Fields of Personalized Medicine and Next-Generation Sequencing
           5.2.4 Market Challenges
                    5.2.4.1 Localization of Business
                    5.2.4.2 Large-Scale Synthesis of Oligonucleotides
                    5.2.4.3 Delivery of Oligonucleotide Drug to Specific Target
    5.3 Industry Trends
    5.4 Porter’s Five Forces Analysis
           5.4.1 Threat of New Entrants
           5.4.2 Threat of Substitutes
           5.4.3 Bargaining Power of Suppliers
           5.4.4 Bargaining Power of Buyers
           5.4.5 Intensity of Competitive Rivalry
    5.5 Supply Chain Analysis
           5.5.1 Key Influencers

6 Oligonucleotide Synthesis Market, By Product & Service (Page No. - 56)
    6.1 Introduction
    6.2 Synthesized Oligonucleotides
           6.2.1 Synthesized Oligonucleotides Market, By Product
                    6.2.1.1 Primers
                    6.2.1.2 Probes
                    6.2.1.3 Large-Scale Synthesis Oligos
                    6.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
                    6.2.1.5 Linkers and Adaptors
           6.2.2 Synthesized Oligonucleotides Market, By Service
                    6.2.2.1 Custom Oligonucleotides
                    6.2.2.2 Pre-Designed Oligonucleotides
           6.2.3 Reagents
           6.2.4 Equipment

7 Oligonucleotide Synthesis Market, By Application (Page No. - 83)
    7.1 Introduction
    7.2 Research
           7.2.1 PCR
           7.2.2 QPCR
           7.2.3 Sequencing
           7.2.4 Gene Synthesis
           7.2.5 Other Research Applications
    7.3 Diagnostics
    7.4 Therapeutics
           7.4.1 Rnai
           7.4.2 Nucleic Acid Aptamers
           7.4.3 DNA/Antisense Oligos
           7.4.4 Immunotherapy Applications

8 Oligonucleotide Synthesis Market, By End User (Page No. - 113)
    8.1 Introduction
    8.2 Academic Research Institutes
    8.3 Pharmaceutical and Biotechnology Companies
    8.4 Diagnostic Laboratories
    8.5 Other End Users

9 Oligonucleotide Synthesis Market, By Region (Page No. - 126)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe (RoE)
    9.4 Asia-Pacific (APAC)
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia-Pacific (RoAPAC)
    9.5 Latin America (Latam)
    9.6 Middle East and Africa (MEA)

10 Competitive Landscape (Page No. - 182)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 Partnerships, Agreements, Contracts, and Collaborations
             10.3.2 Product Launches, Upgrades, and Licenses
             10.3.3 Expansions
             10.3.4 Acquisitions
             10.3.5 Others

11 Company Profiles (Page No. - 192)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Introduction
     11.2 Integrated DNA Technologies, Inc.
     11.3 Merck KGaA
     11.4 Eurofins Genomics
     11.5 Thermo Fisher Scientific Inc.
     11.6 Bioautomation Corporation
     11.7 Agilent Technologies, Inc.
     11.8 Eurogentec S.A.
     11.9 General Electric (GE) Company
     11.10 LGC Biosearch Technologies, Inc.
     11.11 Nitto Denko Avecia Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 235)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments, By Company, 2013–2016
             12.3.1 Product Launches, Upgrades, and Licenses
             12.3.2 Expansions
             12.3.3 Acquisitions.
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Introducing RT: Real-Time Market Intelligence
     12.6 Available Customizations
     12.7 Related Reports
     12.8 Author Details


List of Tables (229 Tables)

Table 1 Global Synthesized Oligonucleotides Market Size, By Region, 2014–2021 (USD Million)
Table 2 North America: Synthesized Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 3 Europe: Synthesized Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 4 Asia-Pacific: Synthesized Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 5 Global Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 6 Global Primers Market Size, By Region, 2014–2021 (USD Million)
Table 7 North America: Primers Market Size, By Country, 2014–2021 (USD Million)
Table 8 Europe: Primers Market Size, By Country, 2014–2021 (USD Million)
Table 9 Asia-Pacific: Primers Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Probes Market Size, By Region, 2014–2021 (USD Million)
Table 11 North America: Probes Market Size, By Country, 2014–2021 (USD Million)
Table 12 Europe: Probes Market Size, By Country, 2014–2021 (USD Million)
Table 13 Asia-Pacific: Probes Market Size, By Country, 2014–2021 (USD Million)
Table 14 Global Large-Scale Synthesis Oligonucleotides Market Size, By Region, 2014–2021 (USD Million)
Table 15 North America: Large-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 16 Europe: Large-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 17 Asia-Pacific: Large-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Intermediate-Scale Synthesis Oligonucleotides Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Intermediate-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Intermediate-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Intermediate-Scale Synthesis Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Linkers and Adaptors Market Size, By Region, 2014–2021 (USD Million)
Table 23 North America: Linkers and Adaptors Market Size, By Country, 2014–2021 (USD Million)
Table 24 Europe: Linkers and Adaptors Market Size, By Country, 2014–2021 (USD Million)
Table 25 Asia-Pacific: Linkers and Adaptors Market Size, By Country, 2014–2021 (USD Million)
Table 26 Global Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 27 Global Custom Oligonucleotides Market Size, By Region, 2014–2021 (USD Million)
Table 28 North America: Custom Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 29 Europe: Custom Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 30 Asia-Pacific: Custom Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 31 Global Pre-Designed Oligonucleotides Market Size, By Region, 2014–2021 (USD Million)
Table 32 North America: Pre-Designed Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 33 Europe: Pre-Designed Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 34 Asia-Pacific: Pre-Designed Oligonucleotides Market Size, By Country, 2014–2021 (USD Million)
Table 35 Global Oligonucleotide Synthesis Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 36 North America: Oligonucleotide Synthesis Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 37 Europe: Oligonucleotide Synthesis Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 38 Asia-Pacific: Oligonucleotide Synthesis Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 39 Global Oligonucleotide Synthesis Equipment Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Oligonucleotide Synthesis Equipment Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Oligonucleotide Synthesis Equipment Market Size, By Country, 2014–2021 (USD Million)
Table 42 Asia-Pacific: Oligonucleotide Synthesis Equipment Market Size, By Country, 2014–2021 (USD Million)
Table 43 Global Oligonucleotide Synthesis Market Size, By Application, 2014-2021 (USD Million)
Table 44 Global Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 45 Global Oligonucleotide Synthesis Market Size for Research Applications, By Region, 2014–2021 (USD Million)
Table 46 North America: Oligonucleotide Synthesis Market Size for Research Applications, By Country, 2014-2021 (USD Million)
Table 47 Europe: Oligonucleotide Synthesis Market Size for Research Applications, By Country, 2014-2021 (USD Million)
Table 48 Asia-Pacific: Oligonucleotide Synthesis Market Size for Research Applications, By Country, 2014-2021 (USD Million)
Table 49 Global Oligonucleotide Synthesis Market Size for PCR Applications, By Region, 2012–2019 ( USD Million)
Table 50 North America: Oligonucleotide Synthesis Market Size for PCR Applications, By Country, 2014-2021 (USD Million)
Table 51 Europe: Oligonucleotide Synthesis Market Size for PCR Applications, By Country, 2014-2021 (USD Million)
Table 52 Asia-Pacific: Oligonucleotide Synthesis Market Size for PCR Applications, By Country, 2014-2021 (USD Million)
Table 53 Global Oligonucleotide Synthesis Market Size for QPCR Applications, By Region, 2014–2021 (USD Million)
Table 54 North America: Oligonucleotide Synthesis Market Size for QPCR Applications, By Country, 2014-2021 (USD Million)
Table 55 Europe: Oligonucleotide Synthesis Market Size for QPCR Applications, By Country, 2014-2021 (USD Million)
Table 56 Asia-Pacific: Oligonucleotide Synthesis Market Size for QPCR Applications, By Country, 2014-2021 (USD Million)
Table 57 Global Oligonucleotide Synthesis Market Size for Sequencing Applications, By Region, 2014–2021(USD Million)
Table 58 North America: Oligonucleotide Synthesis Market Size for Sequencing Applications, By Country, 2014-2021 (USD Million)
Table 59 Europe: Oligonucleotide Synthesis Market Size for Sequencing Applications, By Country, 2014-2021 (USD Million)
Table 60 Asia-Pacific: Oligonucleotide Synthesis Market Size for Sequencing Applications, By Country, 2014-2021 (USD Million)
Table 61 Global Oligonucleotide Synthesis Market Size for Gene Synthesis Applications, By Region, 2014–2021 (USD Million)
Table 62 North America: Oligonucleotide Synthesis Market Size for Gene Synthesis Applications, By Country, 2014-2021 (USD Million)
Table 63 Europe: Oligonucleotide Synthesis Market Size for Gene Synthesis Applications, By Country, 2014-2021 (USD Million)
Table 64 Asia-Pacific: Oligonucleotide Synthesis Market Size for Gene Synthesis Applications, By Country, 2014-2021 (USD Million)
Table 65 Global Oligonucleotide Synthesis Market Size for Other Research Applications, By Region, 2014–2021 (USD Million)
Table 66 North America: Oligonucleotide Synthesis Market Size for Other Research Applications, By Country, 2014-2021 (USD Million)
Table 67 Europe: Oligonucleotide Synthesis Market Size for Other Research Applications, By Country, 2014-2021 (USD Million)
Table 68 Asia-Pacific: Oligonucleotide Synthesis Market Size for Other Research Applications, By Country, 2014-2021 (USD Million)
Table 69 Global Oligonucleotide Synthesis Market Size for Diagnostic Applications, By Region, 2014–2021 (USD Million)
Table 70 North America: Oligonucleotide Synthesis Market Size for Diagnostic Applications, By Country, 2014-2021 (USD Million)
Table 71 Europe: Oligonucleotide Synthesis Market Size for Diagnostic Applications, By Country, 2014-2021 (USD Million)
Table 72 Asia-Pacific: Oligonucleotide Synthesis Market Size for Diagnostic Applications, By Country, 2014-2021 (USD Million)
Table 73 Global Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 74 Global Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Region, 2014–2021 (USD Million)
Table 75 North America: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Country, 2014-2021 (USD Million)
Table 76 Europe: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Country, 2014-2021 (USD Million)
Table 77 Asia-Pacific: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Country, 2014-2021 (USD Million)
Table 78 Global Oligonucleotide Synthesis Market Size for Rnai Applications, By Region, 2014–2021 (USD Million)
Table 79 North America: Oligonucleotide Synthesis Market Size for Rnai Applications, By Country, 2014-2021 (USD Million)
Table 80 Europe: Oligonucleotide Synthesis Market Size for Rnai Applications, By Country, 2014-2021 (USD Million)
Table 81 Asia-Pacific: Oligonucleotide Synthesis Market Size for Rnai Applications, By Country, 2014-2021 (USD Million)
Table 82 Global Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamer Applications, By Region, 2014–2021 (USD Million)
Table 83 North America: Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamer Applications, By Country, 2014-2021 (USD Million)
Table 84 Europe: Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamer Applications, By Country, 2014-2021 (USD Million)
Table 85 Asia-Pacific: Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamer Applications, By Country, 2014-2021 (USD Million)
Table 86 Global Oligonucleotide Synthesis Market Size for DNA/Antisense Oligo Applications, By Region, 2014–2021 (USD Million)
Table 87 North America: Oligonucleotide Synthesis Market Size for DNA/Antisense Oligo Applications, By Country, 2014-2021 (USD Million)
Table 88 Europe: Oligonucleotide Synthesis Market Size for DNA/Antisense Oligo Applications, By Country, 2014-2021 (USD Million)
Table 89 Asia-Pacific: Oligonucleotide Synthesis Market Size for DNA/Antisense Oligo Applications, By Country, 2014-2021 (USD Million)
Table 90 Global Oligonucleotide Synthesis Market Size for Immunotherapy Applications, By Region, 2014–2021 (USD Thousand)
Table 91 North America: Oligonucleotide Synthesis Market Size for Immunotherapy Applications, By Country, 2014-2021 (USD Thousand)
Table 92 Europe: Oligonucleotide Synthesis Market Size for Immunotherapy Applications, By Country, 2014-2021 (USD Thousand)
Table 93 Asia-Pacific: Oligonucleotide Synthesis Market Size for Immunotherapy Applications, By Country, 2014-2021 (USD Thousand)
Table 94 Global Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 95 Global Oligonucleotide Synthesis Market Size for Academic Research Institutes, By Region, 2014–2021 (USD Million)
Table 96 North America: Oligonucleotide Synthesis Market Size for Academic Research Institutes, By Country, 2014–2021 (USD Million)
Table 97 Europe: Oligonucleotide Synthesis Market Size for Academic Research Institutes, By Country, 2014–2021 (USD Million)
Table 98 Asia-Pacific: Oligonucleotide Synthesis Market Size for Academic Research Institutes, By Country, 2014–2021 (USD Million)
Table 99 Global Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 100 North America: Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 101 Europe: Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 102 Asia-Pacific: Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 103 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 104 North America: Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, By Country, 2014–2021 (USD Million)
Table 105 Europe: Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, By Country, 2014–2021 (USD Million)
Table 106 Asia-Pacific: Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, By Country, 2014–2021 (USD Million)
Table 107 Global Oligonucleotide Synthesis Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 108 North America: Oligonucleotide Synthesis Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 109 Europe: Oligonucleotide Synthesis Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 110 Asia-Pacific: Oligonucleotide Synthesis Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 111 Global Oligonucleotide Synthesis Market Size, By Region, 2014–2021 (USD Million)
Table 112 North America: Oligonucleotide Synthesis Market Size, By Country, 2014–2021 (USD Million)
Table 113 North America: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 114 North America: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 115 North America: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 116 North America: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 117 North America: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 118 North America: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 119 North America: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 120 U.S.: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 121 U.S.: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 122 U.S.: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 123 U.S.: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 124 U.S.: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 125 U.S.: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 126 U.S.: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 127 Canada: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 128 Canada: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 129 Canada: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 130 Canada: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 131 Canada: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 132 Canada: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 133 Canada: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 134 Europe: Oligonucleotide Synthesis Market Size, By Country, 2014–2021 (USD Million)
Table 135 Europe: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 136 Europe: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 137 Europe: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 138 Europe: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 139 Europe: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 140 Europe: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 141 Europe: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 142 Germany: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 143 Germany: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 144 Germany: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 145 Germany: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 146 Germany: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 147 Germany: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 148 Germany: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 149 France: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 150 France: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 151 France: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 152 France: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 153 France: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 154 France: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 155 France: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 156 U.K.: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021(USD Million)
Table 157 U.K.: Synthesized Oligonucleotides Market, By Product, 2014–2021 (USD Million)
Table 158 U.K.: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 159 U.K.: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 160 U.K.: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 161 U.K.: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 162 U.K.: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 163 RoE: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 164 RoE: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 165 RoE: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 166 RoE: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 167 RoE: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 168 RoE: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 169 RoE: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 170 Asia-Pacific: Oligonucleotide Synthesis Market Size, By Country, 2014–2021 (USD Million)
Table 171 Asia-Pacific: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 172 Asia-Pacific: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 173 Asia-Pacific: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 174 Asia-Pacific: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 175 Asia-Pacific: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 176 Asia-Pacific: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 177 Asia-Pacific: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 178 China: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 179 China: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 180 China: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 181 China: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 182 China: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 183 China: Oligonucleotide Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 184 China: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 185 Japan: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 186 Japan: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 187 Japan: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 188 Japan: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 189 Japan: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 190 Japan: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 191 Japan: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 192 India: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 193 India: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 194 India: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 195 India: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 196 India: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 197 India: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 198 India: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 199 RoAPAC: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 200 RoAPAC: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 201 RoAPAC: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 202 RoAPAC: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 203 RoAPAC: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 204 RoAPAC: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 205 RoAPAC: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 206 Latin America: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 207 Latin America: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 208 Latin America: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 209 Latin America: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 210 Latin America: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 211 Latin America: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 212 Latin America: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 213 Middle East & Africa: Oligonucleotide Synthesis Market Size, By Product & Service, 2014–2021 (USD Million)
Table 214 Middle East & Africa: Synthesized Oligonucleotides Market Size, By Product, 2014–2021 (USD Million)
Table 215 Middle East & Africa: Synthesized Oligonucleotides Market Size, By Service, 2014–2021 (USD Million)
Table 216 Middle East & Africa: Oligonucleotide Synthesis Market Size, By Application, 2014–2021 (USD Million)
Table 217 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2014–2021 (USD Million)
Table 218 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2014–2021 (USD Million)
Table 219 Middle East & Africa: Oligonucleotide Synthesis Market Size, By End User, 2014–2021 (USD Million)
Table 220 Partnerships, Agreements, Contracts, and Collaborations (2013–2016)
Table 221 Product Launches, Upgrades, and Licenses (2013–2016)
Table 222 Expansions (2013–2016)
Table 223 Acquisitions (2013–2016)
Table 224 Others (2013–2016)
Table 225 Exchange Rates (Used for the Conversion of Eur to USD)
Table 226 Partnerships, Agreements, Contracts, and Collaborations (2013–2016)
Table 227 Product Launches, Upgrades, and Licenses (2013–2016)
Table 228 Expansions (2013–2016)
Table 229 Acquisitions (2013–2016)


List of Figures (53 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Synthesized Oligonucleotides to Dominate the Global Oligonucleotide Synthesis Market During the Forecast Period
Figure 9 Intermediate-Scale Synthesis Oligonucleotides to Register the Highest Growth (2016–2021)
Figure 10 Custom Oligos to Dominate the Oligonucleotide Synthesis Market
Figure 11 Research Applications to Dominate the Oligonucleotide Synthesis Market in 2016
Figure 12 Diagnostic Laboratories End-User Segment to Register the Highest CAGR (2016–2021)
Figure 13 North America to Hold the Largest Share in 2016 and Asia-Pacific to Witness the Highest Growth (2016–2021)
Figure 14 Increasing Research Activities and Growth in the Fields of Molecular Diagnostics and Ngs are Fueling Market Growth
Figure 15 Primers to Form the Major Contributing Segment of the Synthesized Oligonucleotides Market (2016–2021)
Figure 16 Custom Oligos to Dominate the Synthesized Oligonucleotides Services Market From 2016 to 2021
Figure 17 PCR to Command the Largest Share of the Research Applications Market in 2016
Figure 18 Rnai Segment Expected to Register the Highest CAGR During the Forecast Period
Figure 19 Diagnostic Laboratories to Witness Highest Growth Rate in the Forecast Period
Figure 20 China to Grow at the Highest Rate During the Forecast Period
Figure 21 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Porter’s Five Forces Analysis
Figure 23 Synthesized Oligonucleotides to Grow at the Highest CAGR During the Forecast Period
Figure 24 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 25 The Intermediate-Scale Synthesis Segment to Grow at the Highest CAGR During the Forecast Period
Figure 26 Custom Oligonucleotides to Command the Largest Share of Oligonucleotide Synthesis Services Market in 2016
Figure 27 North America to Dominate the Reagents Market in 2016
Figure 28 Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 29 Diagnostic Applications Segment Offer Lucrative Growth Opportunities During the Forecast Period
Figure 30 PCR Segment to Dominate the Research Applications Market in 2016
Figure 31 Asia-Pacific to Grow at the Highest CAGR in the Diagnostic Applications Market During 2016–2021
Figure 32 Rnai Segment to Dominate the Therapeutic Applications Market From 2016 to 2021
Figure 33 Oligonucleotide Synthesis Market, By End User, 2016 vs 2021
Figure 34 Asia-Pacific to Register Highest CAGR in the Oligonucleotide Synthesis Market for Academic Research Institutes
Figure 35 North America to Dominate the Oligonucleotide Synthesis Market for Pharmaceutical & Biotechnology Companies (2016–2021)
Figure 36 Asia-Pacific to Register the Highest CAGR in the Oligonucleotide Synthesis Market for Diagnostic Laboratories
Figure 37 North America: Oligonucleotide Synthesis Market Snapshot
Figure 38 Europe: Oligonucleotide Synthesis Market Snapshot
Figure 39 Asia-Pacific: Oligonucleotide Synthesis Market Snapshot
Figure 40 Latin America: Oligonucleotide Synthesis Market Snapshot
Figure 41 Middle East and Africa: Oligonucleotide Synthesis Market Snapshot
Figure 42 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2013 and 2016
Figure 43 Market Evolution Framework
Figure 44 Global Oligonucleotide Synthesis Market Share Analysis, By Key Player, 2015
Figure 45 Battle for Market Share: Contracts, Agreements, Partnerships, and Collaborations Was the Key Strategy Adopted By Market Players
Figure 46 Product Benchmarking for Top Players in the Oligonucleotide Synthesis Market
Figure 47 Merck KGaA: Company Snapshot
Figure 48 Eurofins Scientific Group: Company Snapshot
Figure 49 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 50 Agilent Technologies, Inc.: Company Snapshot
Figure 51 Kaneka Corporation: Company Snapshot
Figure 52 General Electric Company (GE): Company Snapshot
Figure 53 Nitto Denko Group: Company Snapshot

The oligonucleotide synthesis market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021. The market is mainly driven by factors such as rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, increasing demand for synthetic genes, and increasing R&D expenditure in pharmaceutical and biotechnological companies.

The oligonucleotide synthesis market in this report is segmented on the basis of products and services, applications, end users, and regions. Based on product and services, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is further sub-segmented into products and services. The synthesized oligonucleotide synthesis products segment includes primers, probes, intermediate-scale synthesis oligos, large-scale synthesis oligos and linkers and adaptors. The synthesized oligonucleotides services segment includes custom oligos and pre-designed oligos. The synthesized oligonucleotides segment is expected to dominate the market by holding largest share in 2016 and also experience highest growth during the forecast period. The high growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market.

On the basis of application, the oligonucleotide synthesis market is further divided into research, diagnostic and therapeutic applications. Research applications include PCR, qPCR, sequencing, gene synthesis and other research applications which include nucleic acid-based testing, isothermal nucleic acid technology, binding studies, gel shift assays, and fluorescence in situ hybridization (FISH). The therapeutic applications segment includes RNAi, DNA/antisense oligos, nucleic acid aptamers, and immunotherapy applications. The research application segment is expected to dominate the market however, the diagnostic applications is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the rapidly growing fields of molecular diagnostics (MDx), emerging technologies such as DNA sequencing and next-generation sequencing (NGS) and in vitro diagnostics (IVD).

Based on end-user the oligonucleotide synthesis market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories and other end users that include private laboratories and hospitals. The academic and research institutes is expected to dominate the market. However, diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. This can primarily be attributed to increasing use of synthesized oligonucleotides in molecular diagnostics.

Oligonucleotide Synthesis Market

The global market is dominated by North America, followed by Europe, Asia-Pacific, Latin America, Middle East and Africa. The market in Asia-Pacific is expected to grow at a highest CAGR during the forecast period. Factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region contribute to the growth of this oligonucleotide synthesis in Asia-Pacific region. Furthermore, the increasing focus of prominent players on APAC is another factor driving the growth of this market.

Key market players Agilent Technologies Inc. (U.S.), Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Sigma-Aldrich Corporation (U.S.) (part of Merck KGaA (Germany)).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo